Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study. 1996

D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
November 2010, Journal of the American Academy of Dermatology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
June 1997, Journal of the American Academy of Dermatology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
June 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
January 1995, Journal of the American Academy of Dermatology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
August 1997, Journal of clinical psychopharmacology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
February 1990, Journal of the American Academy of Dermatology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
December 2000, Journal of the American Geriatrics Society,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
December 1990, Nederlands tijdschrift voor geneeskunde,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
November 1996, The British journal of dermatology,
D M Pariser, and R J Pariser, and D Breneman, and M Lebwohl, and R Kalb, and J Moore, and H Moss, and C Parker, and V Fiedler
April 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Copied contents to your clipboard!